Showing results (411-420 of 466) with videos related to

Sort By:
Pageof 47
Seminars in Arthritis and Rheumatism|May 8, 2023
Developing a core outcome set for foot and ankle disorders in rheumatic and musculoskeletal diseases: A scoping review and report from the OMERACT 2022 foot and ankle special interest group sessionLara S Chapman, Jennifer Jones, Anthony C Redmond, et al.
Seminars in Arthritis and Rheumatism|February 7, 2024
Hip and pelvis region MRI reference image atlas for scoring inflammation in peripheral joints and entheses according to the OMERACT-MRI WIPE scoring system in patients with spondyloarthritisMikkel Østergaard, Robert Gw Lambert, Anna Ef Hadsbjerg, et al.
Seminars in Arthritis and Rheumatism|February 7, 2024
The OMERACT whole-body MRI scoring system for inflammation in peripheral joints and entheses (WIPE) in spondyloarthritis - reference image atlas for the knee regionMikkel Østergaard, Marie Wetterslev, Anna Ef Hadsbjerg, et al.
The Journal of Rheumatology|August 3, 2017
Engaging Stakeholders and Promoting Uptake of OMERACT Core Outcome Instrument SetsSean R Tunis, Lara J Maxwell, Ian D Graham, et al.
The Journal of Rheumatology|March 9, 2007
Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schemaMarissa N Lassere, Kent R Johnson, Maarten Boers, et al.
Seminars in Arthritis and Rheumatism|June 28, 2021
Joint and entheseal inflammation in the knee region in spondyloarthritis - reliability and responsiveness of two OMERACT whole-body MRI scoresMarie Wetterslev, Walter P Maksymowych, Robert Gw Lambert, et al.
The Lancet. Rheumatology|January 22, 2024
Colchicine twice a day for hand osteoarthritis (COLOR): a double-blind, randomised, placebo-controlled trialAnna Døssing, Marius Henriksen, Karen Ellegaard, et al.
The Journal of Rheumatology|December 17, 2013
Determining a magnetic resonance imaging inflammatory activity acceptable state without subsequent radiographic progression in rheumatoid arthritis: results from a followup MRI study of 254 patients in clinical remission or low disease activityFrédérique Gandjbakhch, Espen A Haavardsholm, Philip G Conaghan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 18, 2019
A Phase II Trial of Lutikizumab, an Anti-Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With SynovitisRoy M Fleischmann, Henning Bliddal, Francisco J Blanco, et al.
Osteoarthritis and Cartilage Open|March 5, 2024
Toward designing human intervention studies to prevent osteoarthritis after knee injury: A report from an interdisciplinary OARSI 2023 workshopJackie L Whittaker, Raneem Kalsoum, James Bilzon, et al.
Pageof 47